Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 28.27M | $ 265.35K | 0.94% |
3/31/2025 | $ 27.3M | $ 296.66K | 1.09% |
12/31/2024 | $ 26.49M | $ 325.55K | 1.23% |
9/30/2024 | $ 23.84M | $ 357.35K | 1.5% |
6/30/2024 | $ 23.22M | $ 376.22K | 1.62% |
3/31/2024 | $ 21.28M | $ 353.86K | 1.66% |
12/31/2023 | $ 17.47M | $ 368.87K | 2.11% |
9/30/2023 | $ 16.29M | $ 333.6K | 2.05% |
6/30/2023 | $ 15.69M | $ 322.29K | 2.05% |
3/31/2023 | $ 16.01M | $ 308.27K | 1.92% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for IMMUCELL CORP is calculated as follows: SB Comp. [ $ 288.01K ] / Revenues [ $ 15.23M ]
(=) SB Comp % [ 1.89% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |